The largest database of trusted experimental protocols

9 protocols using wst 1 cell viability assay

1

HUVEC Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human umbilical vein endothelial cells (HUVECs American Type Culture Collection, Manassas, VA, USA) were cultured in a CO2 incubator using Medium 199 (M199, LabClinics, Barcelona, Spain) supplemented with penicillin-streptomycin (100 units and 0.1 mg/mL, respectively) and 10% fetal bovine serum (complete M199) in T-25 flasks (SPL Life Sciences Co., Ltd.), allowed to grow up to 70–80% convergence and replated by trypsin treatment. Unspecific toxicity of the samples was tested with the WST-1 cell viability assay (Roche Applied Science, Penzberg, Germany), following the manufacturer’s recommendations. Briefly, HUVECs were seeded in 96-well plates at a density of 5000 cells per well in 100 µL of complete M199. After a 24-h incubation at 37 °C, the medium was removed, and 90 µL of fresh M199 were added together with 10 µL of the sample of interest in PBS. HUVECs were placed back in the incubator for 24 h or 48 h. At the moment of reading, 10 µL of WST-1 reagent was added to each well, and, after an incubation of 3–4 h, absorbance at 440 nm was measured with an EpochTM microplate spectrophotometer (BioTek Instruments Inc., Winooski, VT, USA). For each sample, three different concentrations were tested in triplicates, and each plate contained three seeded wells with 1% bleach (0% viability control) and three wells with 10 µL PBS (100% viability control) as controls.
+ Open protocol
+ Expand
2

Cytotoxicity Evaluation of Glucose Treatments

Check if the same lab product or an alternative is used in the 5 most similar protocols
To determine the cytotoxicity of the treatments used in our experiments, the WST-1 Cell Viability Assay (Roche) was used. Cells were seeded (5.0x104/well) onto a 96-well plate and were allowed to attach overnight. The following morning, the full medium was removed and was replaced with 100μL of serum-free medium containing various concentrations of D-glucose (5mM, 10mM, 15mM, 25mM, 50mM, 100mM). Following 24 hours of incubation with glucose, 10μL of WST-1 reagent was added to each well. The plate incubated for 1.5 hours at 37°C to produce a colour reaction. Absorbance was measured with a Multiskan FC Microplate Photometer (Thermo Scientific, Finland) at 450nm with a reference wavelength of 690nm. Survival was determined by the difference between the absorbances at 450nm and 690nm.
+ Open protocol
+ Expand
3

Cell Viability Assessment Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was assessed using the Muse™ Cell Analyzer and the Muse™ Count and Viability Kit according to manufacturer’s instructions (EMD Millipore, Billerica, MA, USA; Cat #MCH100102) or the WST-1 cell viability assay (Roche, IN, USA; Cat #5015944001). The plates were mixed on an Orbital Shaker on setting 2 (Bellco, NJ, USA; Cat #7744-20220) at room temperature for 30 min and absorbance was measured at 630 nm using an iMark™ Microplate Absorbance Reader (Bio-Rad, CA, US). MTT cell viability assay (Thermo Fisher MA, USA; cat #V-13154) was performed by incubating culture plates with MTT reagent for four hours at 37 °C, adding SDS lysis buffer, and incubating for four hours to overnight at 37 °C. Absorbance was measured at 570 nm with a plate reader as above.
+ Open protocol
+ Expand
4

Glucose-Induced Cytotoxicity in HRECs

Check if the same lab product or an alternative is used in the 5 most similar protocols
As previously described62 , the cytotoxicity of glucose treatments (5 mM and 25 mM) in HRECs were determined using the WST-1 Cell Viability Assay (Roche). Viability was assessed at various durations of incubation (0, 24, and 48 hours). Absorbances were first measured at 450 nm, with the Multiskan FC Microplate Photometer (Thermo Fisher Scientific), and then corrected using 690 nm as the reference wavelength.
+ Open protocol
+ Expand
5

Amyloid-Induced Neuronal Degeneration

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell culture associated reagents were purchased from Gibco, Thermo Fisher: Dulbecco's Modified Eagle's Medium (DMEM), 0.25% Trypsin-EDTA solution. Penicillin/Streptomycin solution was from PAA, Cambridge, UK. Brain derived neurotrophic factor was obtained from Alomone Labs, Jerusalem, Israel. Recombinant human Aβ40 and Aβ42 peptides (TFA salts, purity >97%) were from rPeptide, Bogart, GA 30622, USA. Tween-20 (Ferak, Berlin, Germany) WST-1 cell viability assay was purchased from Roche, Switzerland, and the Caspase-Glo assay kit from Promega Co, Madison, WI, USA. 1,1,1,3,3,3-hexafluoro-2-propanol (HFIP), 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), poly-L-lysine, retinoic acid, CalceinAM (calcein-acetoxymethyl ester), sodium chloride; goat serum; staurosporine, 4',6-diamidino-2-phenylindole (DAPI), PBS were obtained from Sigma Aldrich.
Antibodies against a microtubule component βIII-tubulin TUJ-1 were obtained from Abcam, Cambridge, UK; anti-APP/Aβ antibody—from Millipore, Darmstadt, Germany. Guinea pig anti-Synaptophysin1 was from Synaptic Systems, Goettingen, Germany. Secondary antibodies were Alexa-488 and Alexa-568 from Invitrogen.
+ Open protocol
+ Expand
6

Cytotoxicity Evaluation of Immunotoxin and DOC

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cytotoxicity of the immunotoxin and DOC was measured by WST-1 cell viability assay (Roche Diagnostics). For this, 1.5 × 104 cells were seeded in a 96-well plate and incubated overnight. Then cells were incubated with immunotoxin and DOC alone or in combination. After 24, 48, and 72 h, 15 μl/well WST-1 reagent was added and plates were incubated until the maximum absorbance at 450 nm reached values of about 2.5 optical density (OD). For the determination of the IC50-values, defined as the immunotoxin / DOC concentration leading to a reduction of 50% cell viability, non-linear regression [log (inhibitor) vs. response (three parameters)] was estimated (software GraphPad Prism 6). Mutually non-exclusive Combination Index (C. Index) was determined according to Bijnsdorp et al. with values < 0.9 indicating synergistic cytotoxicity of both substances [47 (link)].
+ Open protocol
+ Expand
7

Cell Viability Assay Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cell viability was determined at different time points using a WST-1 cell viability assay according to the manufacturer's protocol (Roche Diagnostics, Mannheim, Germany). Triplicate wells containing 5 × 103 cells were evaluated for viability. The absorbance was measured using a microplate reader at a wavelength of 450 nm (BioTek Instruments, Inc., Winooski, VT, USA). The relative cell viability was calculated as the A450 nm (MUC1-silenced or overexpressed cells at Tn)/A450 nm (control at Tn) × 100%. VT, USA), from three independent experiments.
+ Open protocol
+ Expand
8

Cell Viability Assay with siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded at a density of 2000 cells/well in 96-well culture plates and transfected with siRNA for 72 h. The amount of viable cells was assessed by a WST-1 cell viability assay (Roche Applied Science). Absorbance was measured in an Anthos 2020 enzyme-linked immunosorbent assay plate reader (Anthos Labtec Instruments).
+ Open protocol
+ Expand
9

Cytotoxicity Evaluation of MSN Nanocarriers

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cytotoxicity of MSN nanocarriers (without siRNA) was evaluated using WST-1 cell viability assay (Roche Diagnostics, Mannheim, Germany). A total of 10,000 MDA-MB-231 cells per well were grown in a 96-well plate in DMEM (10% fetal calf serum [FCS], 1% amino acids, 1% penicillin–streptomycin) and incubated overnight to adhere. Then, MSN nanocarriers were sonicated for 15 min and added to 1 mL of pre-warmed (37°C) growth medium at three different fivefold increasing concentrations of 2 μg, 10 μg and 50 μg. Then, the growth medium containing particles was further sonicated for 15 min. The growth media of cells in 96-well plates were replaced with media containing three different concentrations of MSN nanocarriers. A 5 μM of staurosporine (toxin) was added as a positive control, whereas negative control cells were untreated (pure cell media only). After incubating the particles for time points from 24 h to 72 h at 37°C, 5% CO2, 10 μL of WST-1 cell proliferation reagent (Roche Diagnostics) was added to the wells containing 100 μL of cell growth media, and the plate was again allowed to incubate for 3 h at 37°C, 5% CO2. After incubation period, the absorbance was read at 430 nm by Tecan Ultra microplate reader (MTX Lab Systems, Inc.). The number of viable cells was correlated with the observed absorbance from each individual sample.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!